Weight loss is good – even if you’re not overweight!
It is known that obesity increases the risk of developing T2D but one in ten sufferers are not obese or overweight. Results from a study
It is known that obesity increases the risk of developing T2D but one in ten sufferers are not obese or overweight. Results from a study
A once-weekly 2mg injection of Novo Nordisk’s Ozempic semaglutide product Ozempic has been approved for use in America, following results of the SUSTAIN FORTE trial,
There are good reasons to try to control T2D by weight loss. The biggest study to date, involving 3m people with an average age of
One in four children and young adults aren’t diagnosed with T1D until they have potentially fatal diabetic ketoacidosis – when the body doesn’t have enough
The drive towards personalised care continues with the development of new software called the Healum app. Results of an 18-month trial presented at the Diabetes
Stretchy skin-like wearable electronic devices are just around the corner, offering the chance to transform the lives of millions of people living with diabetes who
University College London’s Global Business School for Health has partnered with the pharmaceutical company Roche UK to offer a new fully-funded MBA Health scholarship open
Although there has been much discussion about sharing electronic health records, information from home wearable devices is not shared with outpatients clinics or hospitals so
A team led by mechanical engineers from the Massachusetts Institute of Technology (MIT) in America has patented two new devices to reduce the rigmarole of
Many of the UK’s biggest restaurant chains have told the Observer newspaper they won’t change their ingredients when regulations are introduced in April requiring them